1069 Stock Overview
An investment holding company, engages in forestry management business in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
China Health Technology Group Holding Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.052 |
52 Week High | HK$0.89 |
52 Week Low | HK$0.042 |
Beta | 0.47 |
11 Month Change | -3.70% |
3 Month Change | -29.73% |
1 Year Change | n/a |
33 Year Change | -95.67% |
5 Year Change | -94.80% |
Change since IPO | -99.59% |
Recent News & Updates
Shareholder Returns
1069 | HK Forestry | HK Market | |
---|---|---|---|
7D | -1.9% | -3.8% | -3.5% |
1Y | n/a | -24.1% | -1.0% |
Return vs Industry: Insufficient data to determine how 1069 performed against the Hong Kong Forestry industry.
Return vs Market: Insufficient data to determine how 1069 performed against the Hong Kong Market.
Price Volatility
1069 volatility | |
---|---|
1069 Average Weekly Movement | 12.8% |
Forestry Industry Average Movement | 9.5% |
Market Average Movement | 6.3% |
10% most volatile stocks in HK Market | 13.1% |
10% least volatile stocks in HK Market | 3.3% |
Stable Share Price: 1069's share price has been volatile over the past 3 months.
Volatility Over Time: 1069's weekly volatility has decreased from 22% to 13% over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 27 | Yibin Wang | www.caflc.co |
China Health Technology Group Holding Company Limited, an investment holding company, engages in forestry management business in the People’s Republic of China. It operates through Forestry Business and Ginseng Business segments. The company involved in the plantation, logging, and sale of timber related products; and ginseng planation and trading business.
China Health Technology Group Holding Company Limited Fundamentals Summary
1069 fundamental statistics | |
---|---|
Market cap | HK$37.24m |
Earnings (TTM) | HK$210.98m |
Revenue (TTM) | HK$60.17m |
0.2x
P/E Ratio0.6x
P/S RatioIs 1069 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1069 income statement (TTM) | |
---|---|
Revenue | CN¥54.72m |
Cost of Revenue | CN¥44.52m |
Gross Profit | CN¥10.20m |
Other Expenses | -CN¥181.67m |
Earnings | CN¥191.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.27 |
Gross Margin | 18.64% |
Net Profit Margin | 350.66% |
Debt/Equity Ratio | 654.1% |
How did 1069 perform over the long term?
See historical performance and comparison